UK markets closed

Bio-Techne Corporation (TECH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
63.09-0.60 (-0.94%)
As of 01:54PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
1,144,999
1,136,702
1,105,599
931,032
738,691
Cost of revenue
376,362
366,887
349,103
298,182
255,497
Gross profit
768,637
769,815
756,496
632,850
483,194
Operating expenses
Research development
93,045
92,493
87,140
70,603
65,192
Selling general and administrative
381,050
352,438
339,001
289,924
240,882
Total operating expenses
507,981
478,817
460,668
390,160
334,347
Operating income or loss
260,656
290,998
295,828
242,690
148,847
Interest expense
14,291
11,215
11,309
13,952
19,197
Total other income/expenses net
1,378
55,466
16,073
-81,036
146,222
Income before tax
251,458
338,659
301,386
148,175
276,477
Income tax expense
27,296
53,217
38,287
8,590
47,181
Income from continuing operations
224,162
285,442
263,099
139,585
229,296
Net income
224,162
285,263
272,051
140,410
229,296
Net income available to common shareholders
224,114
285,193
271,930
140,324
229,072
Basic EPS
1.56
1.81
1.73
0.91
1.50
Diluted EPS
1.52
1.76
1.66
0.87
1.46
Basic average shares
157,479
157,179
156,874
154,986
152,804
Diluted average shares
161,797
161,855
164,114
161,932
157,604